Copertina

Factors Influencing Medication Adherence in Heart Failure Patients—A Survey Among Cardiac Healthcare Providers

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Ingibjorg Gunnthorsdottir, Anna Birna Almarsdottir, Karl Andersen, Anna I. Gunnarsdottir, Erla Svansdottir, Hafsteinn Einarsson, Inga Jona Ingimarsdottir
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Clinical Pharmacology & Therapeutics
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Effects of Sacubitril/Valsartan on Survival in Patients with Heart Failure and Significant Valvular Heart Disease
di: Donna Shu‐Han Lin, et al.
Pubblicazione: (2024)

Contemporary Use of β‐Blockers in Heart Failure Patients With and Without Atrial Fibrillation: A Nationwide Database Analysis
di: Michikazu Nakai, et al.
Pubblicazione: (2024)

The Feasibility and Quality of the European Prescribing Exam: An International Multicenter Pilot Study Among 3109 Medical Students From 16 Medical Schools
di: Erik M. Donker, et al.
Pubblicazione: (2025)

Editorial: UDCA Dosing in PBC – Between Guideline Adherence and Clinical Reality
di: Helena Hernández‐Évole, et al.
Pubblicazione: (2026)

Editorial: UDCA Dosing in PBC—Between Guideline Adherence and Clinical Reality: Authors' Reply
di: Ellen Werner, et al.
Pubblicazione: (2026)

A National Study Among Diverse US Populations of Exposure to Prescription Medications with Evidence‐Based Pharmacogenomic Information
di: Loren Saulsberry, et al.
Pubblicazione: (2025)

Pain and Sedative Medication Use Among Individuals With Inflammatory Bowel Disease: A Nationwide Population‐Based Cohort Study
di: Samantha Baillie, et al.
Pubblicazione: (2025)

The Magnitude of Polypharmacy and Role of Disease Severity and Patient Sex in Medication Use Among Patients With MASLD Enrolled in TARGET‐NASH
di: Brent A. Neuschwander‐Tetri, et al.
Pubblicazione: (2025)

Editorial: Getting to the Heart of the Matter in IBD
di: Ashwin N. Ananthakrishnan
Pubblicazione: (2025)

Measuring the Impact of the Substitution of Innovator Biologics With Biosimilars on Uptake and Costs Among Ontario Public Drug Benefit Recipients
di: Anita Iacono, et al.
Pubblicazione: (2026)

Research Communication: Healthcare Utilisation Patterns in Patients With Irritable Bowel Syndrome Across an Integrated Healthcare System
di: Neil S. Zheng, et al.
Pubblicazione: (2025)

Editorial: Decoding Gut Failure in Cirrhosis—Villin‐1 and the Emergence of a Seventh Organ Failure. Authors' Reply
di: David Tornai, et al.
Pubblicazione: (2026)

Editorial: Getting to the Heart of the Matter in IBD—Authors' Reply
di: Ramin Ebrahimi, et al.
Pubblicazione: (2025)

Major Adverse Cardiac Events with Ondansetron: A Systematic Review
di: Michael Cristian Garcia, et al.
Pubblicazione: (2025)

Untargeted Metabolomics Identifies N‐Lactoyl‐Amino Acids as Dose‐Responsive Plasma Biomarkers of Metformin Adherence in Type 2 Diabetes
di: Tomas Cajka, et al.
Pubblicazione: (2026)

Research Communication: Optimising Use of Stool Gluten Immunogenic Peptide Tests for Monitoring Adherence to Gluten‐Free Diet in Patients With Coeliac Disease
di: Juan P. Stefanolo, et al.
Pubblicazione: (2025)

Meta‐Analysis: Prevalence and Incidence of Gastroparesis Following Lung or Heart Transplantation
di: Mohamed H. Eldesouki, et al.
Pubblicazione: (2026)

Research Communication: Reflux Disease May Constitute a Risk Factor for Colonic Neoplasia
di: Amnon Sonnenberg, et al.
Pubblicazione: (2025)

Editorial: Patient Reported Outcomes Provide Insight Into Disease Severity for People Living With Primary Sclerosing Cholangitis
di: Aisha Alawi, et al.
Pubblicazione: (2025)

MRI Provides New Insights Into the Pharmacologic Mechanism of Bisacodyl: A Blueprint for Understanding Intestinal Drug Mechanisms
di: Kathleen M. Giacomini
Pubblicazione: (2025)

Burden of Invasive Fungal Diseases in Patients With Alcohol‐Related Hepatitis and Organ Failure
di: Charlotte Mouliade, et al.
Pubblicazione: (2025)

Cutaneous Adverse Drug Reactions Associated With BRAF and MEK Inhibitors: A Real‐World Analysis of WHO Pharmacovigilance Data
di: Natalia Sauer, et al.
Pubblicazione: (2026)

Modeling Supports Combinatorial Effects Between Pharmacological and Non‐Pharmacological Interventions to Prevent Opioid‐Induced Cardiac Arrest
di: Bradlee Thrasher, et al.
Pubblicazione: (2026)

Pseudo‐Worsening of Kidney Function Due to Inhibition of Renal Creatinine Secretion: Quality of Information Provided in Prescribing Information/SmPC
di: Michael I. Sponfeldner, et al.
Pubblicazione: (2024)

Association Discovery Approach in Healthcare Big Data to Identify Drug Safety and Drug Repurposing Signals
di: George S. Q. Tan, et al.
Pubblicazione: (2025)

Editorial: Decoding ACLF—Sub‐Phenotyping to Advance Precision Medicine in Acute‐On‐Chronic Liver Failure
di: Amy Sangam, et al.
Pubblicazione: (2024)

Prevalence of Opioid Use and Associated Healthcare Outcomes in Rome IV Irritable Bowel Syndrome in the United Kingdom
di: Mohsin F. Butt, et al.
Pubblicazione: (2025)

Advancing Principled Pharmacoepidemiologic Research to Support Regulatory and Healthcare Decision Making: The Era of Real‐World Evidence
di: Rohini K. Hernandez, et al.
Pubblicazione: (2025)

Novel Symptom Subgroups in Patients With Irritable Bowel Syndrome Are Associated With Healthcare Utilisation in Secondary and Tertiary Care
di: Vivek C. Goodoory, et al.
Pubblicazione: (2026)

Editorial: Ulcerative Colitis Management in the Biologic Era–Data From the English Healthcare Databases. Authors' Reply
di: J. Couch, et al.
Pubblicazione: (2025)

Prenatal and Early Childhood Exposure to Antibiotics or Gastric Acid Inhibitors and Increased Risk of Epilepsy: A Nationwide Population‐Based Study
di: Unnur Gudnadottir, et al.
Pubblicazione: (2025)

Robust Predictive Performance of the SALT‐M Score for Clinical Outcomes in Asian Patients With Acute‐on‐Chronic Liver Failure
di: Kunhee Kim, et al.
Pubblicazione: (2024)

Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Healthy Volunteers and Patients with Chronic Kidney Disease
di: Pamela Navarro‐Gonzales, et al.
Pubblicazione: (2024)

Editorial: Are Antidepressant Medications Safe in Inflammatory Bowel Disease?
di: Matthew D. Coates, et al.
Pubblicazione: (2025)

Barriers to Medical Care Are Frequently Reported by Patients With Cirrhosis
di: William Chai, et al.
Pubblicazione: (2025)

Drug‐Event Pairs as Indicators for the Detection of Adverse Drug Reactions during Hospitalization in Routinely Collected Electronic Data Sources
di: Anna Maria Wermund, et al.
Pubblicazione: (2025)

Cohort Study: Long‐Term Risk and Healthcare Burden of Irritable Bowel Syndrome Following Infection Enteritis in 202,244 Patients
di: Mohamed H. Eldesouki, et al.
Pubblicazione: (2026)

Effect of Nucleos(t)ide Analogues Withdrawal on Survival Outcomes in Patients With Hepatitis B Virus‐Related Acute‐on‐Chronic Liver Failure
di: Yanxue Lin, et al.
Pubblicazione: (2025)

Cytochrome P450 2D6 Poor Metabolizers and Risperidone Treatment Failure: A 1‐Year Longitudinal Study
di: Marianna Piras, et al.
Pubblicazione: (2025)

Evolving Recommendations for Patient Populations Among Oncology Medicines: A Quantitative and Qualitative Analysis
di: Milou A. Hogervorst, et al.
Pubblicazione: (2025)